Where to Invest $1,000 Right Now

Richard Hemming


Our subscribers make money from the Small Caps we tip because they generate big growth. Today we give you 3 of our 10 Best Stocks To Buy NowThese are the stocks our analyst team agree offer the best risk/reward return. 

When I first started investing a veteran in the industry told me: don’t worry, it’s like fishing. Sooner or later you’ll catch a big one, you just have to keep bating up. We’ve done the fishing so that you can invest in Small Caps with confidence. ​Use this article to start investing in our favourite Small Cap stocks.

You can invest $1,000 and start to grow your ASX Small Cap Portfolio. This list is in alpha order. Join now and login to view our full company research.

Catapult (ASX: CAT) 
Radar Rating: SPEC BUY

Industry: Technology
Market Cap: $411M
Dividend Yield: 0% 
12 month high: $2.46
Price @ 22/04/2021: $2.09

Catapult is an early stage technology company whose sports analytics products are gaining traction around the world, with customers including college basketball, Premier League soccer, the Egypt National Football Team and NSW Women’s Rugby League. The stock represents a recovery play on the opening up of sports events, with the company’s immediate profitability also impacted by its transition to a pure software as a service model, as it ceases capital sales. It is no longer selling devices outright, but selling them in plans, similar to mobile phones. We value this stock at over $2 but it is climbing fast. We wouldn’t be surprised if it disappears off our best buys soon, but we will continue to like its business model and potential. 

Medical Developments (ASX: MVP) 
Radar Rating: SPEC BUY

Industry: Pharmaceuticals
Market Cap: $418M
Dividend Yield: 0% 
12 month high: $2.46
Price @ 22/04/2021: $5.95

MVP has always had a number of irons in the fire. Sales have remained quite subdued, but potential device approvals in the US and China remain on the cards; as does its development with the CSIRO of an alternative manufacturing method for generic active pharmaceutical ingredients. MVP expect a sales rebound in 2H21 as COVID-19 restrictions ease.

Tassal (ASX: TGR) 
Radar Rating: SPEC BUY

Industry: Foods
Market Cap: $814M
Dividend Yield: 3.6% 
12 month high: $4.13
Price @ 22/04/2021: $3.84

This company has been a proven performer for a number of years but has had a difficult pandemic. The good news is that its growth potential remains in tact and Tassal should come out stronger, having faced a double whammy of deteriorating salmon prices and increasing costs due to supply difficulties and an appreciating local currency. The stock looks good value whether or not salmon prices recover. The company is managing its debt situation, which provides an opportunity for investors.

In our weekly Small Cap Stock Reports our analyst team provide subscribers with a exclusive list of 10 Best Stocks To Buy Now. These are the Small Caps that fly Under the Radar to supercharge your wealth. 

Start investing in our favourite Small Cap stocks now.
Join now 

About the Author

Richard Hemming

Richard Hemming (r.hemming@undertheradarreport.com.au) is an independent analyst who edits www.undertheradarreport.com.au, which provides investment opportunities in Small Caps that you won’t get anywhere else.

Under the Radar Report is licensed to give general financial advice only (AFSL: 409518). The author does not own shares in any of the stocks mentioned.

Did you miss?

As Seen In